0
Adamas Pharmaceuticals Inc
- 51-200 Employees
- Based in Emeryville, California
Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. The company’s lead product candidate ADS-5102, which completed the Phase II/III clinical trial for the treatment of Parkinson's disease, known as levodopa induced dyskinesia.
Adamas Pharmaceuticals Inc
Most Recent Responsibility Report
MOST RECENT
Shipping Information
Request Information
Adamas Pharmaceuticals Inc does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Our service enables potential investors to review the most recent and archived Adamas Pharmaceuticals Inc Sustainability Report, Adamas Pharmaceuticals Inc Corporate Social Responsibility Report, Adamas Pharmaceuticals Inc CSR Report, Adamas Pharmaceuticals Inc Corporate Responsibility, Adamas Pharmaceuticals Inc CR Report, Adamas Pharmaceuticals Inc Citizenship Report, Adamas Pharmaceuticals Inc ESG Report, and Adamas Pharmaceuticals Inc Environmental Report online.